Manulife (Manufacturers Life Insurance)
GTHX

Manulife (Manufacturers Life Insurance)’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,547
Closed -$133K – 3177
2022
Q1 		$133K Sell
17,547
-4,143
-19% -$39.3K ﹤0.01% 2904
2021
Q4 		$221 Buy
21,690
+444
+2% +$5.66K ﹤0.01% 2840
2021
Q3 		$285K Sell
21,246
-1,262
-6% -$20.6K ﹤0.01% 2716
2021
Q2 		$494K Buy
22,508
+2,593
+13% +$57.6K ﹤0.01% 2444
2021
Q1 		$479K Sell
19,915
-852
-4% -$19.8K ﹤0.01% 2305
2020
Q4 		$374K Buy
20,767
+213
+1% +$3.18K ﹤0.01% 2388
2020
Q3 		$237K Hold
20,554
– – ﹤0.01% 2456
2020
Q2 		$497K Sell
20,554
-1,355
-6% -$22.4K ﹤0.01% 1977
2020
Q1 		$241K Buy
21,909
+1,393
+7% +$26K ﹤0.01% 2214
2019
Q4 		$542K Sell
20,516
-600
-3% -$14K ﹤0.01% 2005
2019
Q3 		$717K Sell
21,116
-103
-0.5% -$3.25K ﹤0.01% 1816
2019
Q2 		$651K Buy
+21,219
New +$447K ﹤0.01% 1885
2018
Q4 		– Sell
-13,892
Closed -$726K – 2863
2018
Q3 		$726K Sell
13,892
-1,615
-10% -$88.1K ﹤0.01% 2020
2018
Q2 		$674K Buy
15,507
+4,707
+44% +$202K ﹤0.01% 2157
2018
Q1 		$401K Buy
10,800
+3,826
+55% +$102K ﹤0.01% 2479
2017
Q4 		$138K Buy
6,974
+80
+1% +$1.72K ﹤0.01% 3275
2017
Q3 		$171K Buy
+6,894
New +$127K ﹤0.01% 3100

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GTHX Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 17,547 shares — an estimated $133K sold.

Manulife (Manufacturers Life Insurance) first reported a position in GTHX in Q3 2017 and held it in 17 quarters. The position peaked at $726K in Q3 2018. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 17,547 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $133K.
  • Manulife (Manufacturers Life Insurance) first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2017 and held it in 17 quarters.
  • Manulife (Manufacturers Life Insurance)'s G1 Therapeutics, Inc. Common Stock position peaked at $726K in Q3 2018.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.